
Pharmaceutical stakeholders have called for greater innovation, improved quality standards and stronger collaboration among manufacturers, regulators, pharmacists and other players to strengthen Nigeria’s pharmaceutical industry and improve access to safe and effective medicines.
The stakeholders made the call at the opening ceremony, project luncheon and plenary sessions of the Ogun State Chapter of the Association of Industrial Pharmacists of Nigeria (NAIP) Week, held on Wednesday, 23 September, at Ijoko, Ogun State.
The conference was organised around the theme, “Production Innovation, Quality Standard: Collaboration and Advancement in Technology of Pharmaceutical Industry in Nigeria,” with the Director-General of the National Agency for Food and Drug Administration and Control (NAFDAC), Prof. Mojisola Adeyeye, as keynote speaker.
Representing the NAFDAC DG, Pharmacist Samson Fatoki said the rapidly changing healthcare environment, particularly developments in artificial intelligence, biotechnology, personalised medicines and advanced therapy medicines, required Nigeria’s pharmaceutical industry to embrace innovation or risk being left behind.

He recalled that the COVID-19 pandemic exposed the vulnerability created by Nigeria’s dependence on imported medicines, stressing the need for innovative approaches and stronger local manufacturing capacity.
Fatoki highlighted several regulatory initiatives introduced by NAFDAC to encourage local production and improve quality, including the 5+5 regulatory policy, which provides importers with an initial five-year period and another five years to develop a blueprint for migrating products to local manufacturing.
He said the agency had also expanded its ceiling list from nine to 36 products that could be manufactured locally, while introducing layout reviews, centralised GMP inspections, risk-based regulation and other measures aimed at improving compliance with international standards.
According to him, Nigeria had 184 pharmaceutical manufacturing sites as of September 2026, compared with 165 in 2019, while the proportion of manufacturers meeting GMP standards had risen from about five per cent to approximately 32 per cent. He added that the figure was approaching 40 per cent and could reach about 60 per cent by the following year.
He further disclosed that 78 products had, as of March 2026, shown potential to migrate to local manufacturing, while drug imports had dropped significantly from more than 450 million metric tons in 2021 to about 100 million metric tons.
Fatoki urged manufacturers to sustain investment in innovation and quality, while strengthening supply-chain controls. He cited NAFDAC initiatives such as Scan to Verify, the NAFDAC Green Book, MedSafety and the Mobile Authentication Service as part of measures to protect the public from substandard and falsified medicines.
He also said NAFDAC was advancing digitalisation and regulatory harmonisation while working towards higher international regulatory standards.
Also speaking, the Father of the Day and Managing Director of Jawa International, Chief Varkey Verghese, said innovation remained critical to the development of the pharmaceutical industry.
Verghese explained that innovation could take place in drug formulations, packaging and other aspects of pharmaceutical production, noting that the industry must continuously adapt to emerging trends.
He said compliance with regulatory requirements would boost confidence in medicines manufactured in Nigeria and enhance their acceptability in international markets.
Verghese also stressed the importance of pharmacovigilance and post-marketing surveillance, noting that continuous monitoring of medicines after approval was essential to identifying safety concerns and protecting patients.
Representing the NAIP National Chairman, Pharm. Bankole Ezebuilo, Pharmacist Emeka Ndineche congratulated the Ogun State chapter for its activities and urged its leadership to sustain and scale up its achievements.
Ndineche described NAIP Ogun as one of the reliable branches that the national body had consistently relied upon to achieve important milestones, assuring the branch of continued support from the national leadership.
Earlier, the Chairman of NAIP Ogun State Branch, Pharmacist (Mrs) SerahPearl Kolade, called for greater cooperation among pharmacists, pharmaceutical manufacturers and other stakeholders in the state.
Kolade said the conference theme reflected the urgent need for stakeholders to work together to promote innovation, strengthen quality assurance and deploy technology across the pharmaceutical value chain.
She urged manufacturers and other industry players to see collaboration as a means of sharing knowledge, improving production processes and developing solutions that would enhance the quality, safety and availability of medicines for Nigerians.
The event witnessed two plenary sessions. The first plenary session, titled “Safeguarding Medicines: Advancing Innovation, Compliance and Patient Trust,” was moderated by the Production Head of May & Baker Plc, Pharm. Ariike Mbaneme.
The second session, “Ensuring Drug Product Safety: Control Strategies from Development to Distribution,” was moderated by Pharm. Emmanuel Ogana, Superintendent Pharmacist at Ranbaxy-Sun Pharma Nigeria Limited. The Provost, College of Pharmacy, Afe Babalola University, Ado Ekiti, Prof. (Mrs) Mbang Femi-Oyewo, and the Marketing Director, Sagar Vitaceutics, Pharm. Adeoti Ademola were the speakers.
The association also used the occasion to launch its brand-new bus.





